Ifosfamide neurotoxicty in a young female with a remarkable response to ThiamineIMTIAZ, Saba; MUZAFFAR, Narjis.Journal of the Pakistan Medical Association. 2010, Vol 60, Num 10, pp 867-869, issn 0030-9982, 3 p.Article

DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamideSTRUCK, R. F; DAVIS, R. L; BERARDINI, M. D et al.Cancer chemotherapy and pharmacology. 2000, Vol 45, Num 1, pp 59-62, issn 0344-5704Article

Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animalsHANSEN, Ryan J; LUDEMAN, Susan M; PAIKOFF, Sari J et al.DNA repair. 2007, Vol 6, Num 8, pp 1145-1154, issn 1568-7864, 10 p.Article

Determination of 4-hydroxyifosfamide concomitantly with ifosfamide and its dechloroethylated metabolites using gas chromatography and a nitrogen phosphorus-selective detectorGOURMEL, B; GRANVIL, C. P; DENIS, S. L et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 732, Num 1, pp 3-15, issn 1387-2273Article

Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphomaFELDMAN, Tatyana; MATO, Anthony R; VALENTINETTI, Marisa et al.British journal of haematology. 2014, Vol 166, Num 1, pp 77-83, issn 0007-1048, 7 p.Article

Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitalsMERGER, Delphine; TANGUAY, Cynthia; LANGLOIS, Éric et al.International archives of occupational and environmental health. 2014, Vol 87, Num 3, pp 307-313, issn 0340-0131, 7 p.Article

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I studyHAMBERG, P; BOERS-SONDEREN, M. J; VAN DER GRAAF, W. T. A et al.British journal of cancer. 2014, Vol 110, Num 4, pp 888-893, issn 0007-0920, 6 p.Article

First-Line Combination Chemotherapy with Cisplatin, Etoposide and Ifosfamide for the Treatment of Disseminated Germ Cell Cancer: Re-Evaluation in the Granulocyte Colony-Stimulating Factor EraTANAKA, Hajime; YUASA, Takeshi; FUJII, Yasuhisa et al.Chemotherapy (Basel). 2013, Vol 59, Num 6, pp 441-446, issn 0009-3157, 6 p.Article

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin's lymphomaKIM, Seon-Kyeong; SONG, Moo-Kon; JOO SEOP CHUNG et al.International journal of hematology. 2013, Vol 98, Num 5, pp 543-548, issn 0925-5710, 6 p.Article

Current questions in soft tissue sarcoma: further steps with Yondelis^®REICHARDT, Peter.Expert review of anticancer therapy. 2013, Vol 13, Num 6, pp 25-32, issn 1473-7140, 8 p., SUP1Article

A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphomaGEORGE, B; BENSON, W; HERTZBERG, M. S et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 7, pp 1001-1002, issn 0268-3369, 2 p.Article

Long term renal toxicity of ifosfamide in adult patients ― 5 year dataFARRY, James K; FLOMBAUM, Carlos D; LATCHA, Sheron et al.European journal of cancer (1990). 2012, Vol 48, Num 9, pp 1326-1331, issn 0959-8049, 6 p.Article

Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphomaSANDLUND, J. T; PUI, C.-H; RIBEIRO, R. C et al.Annals of oncology. 2011, Vol 22, Num 2, pp 468-471, issn 0923-7534, 4 p.Article

Frontline Treatment of Localized Osteosarcoma Without Methotrexate: Results of the St. Jude Children's Research Hospital OS99 TrialDAW, Najat C; NEEL, Michael D; RAO, Bhaskar N et al.Cancer. 2011, Vol 117, Num 12, pp 2770-2778, issn 0008-543X, 9 p.Article

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma PatientsSOO HYEON LEE; MYUNG HEE CHANG; KYUNG KEE BAEK et al.Oncology. 2011, Vol 80, Num 3-4, pp 257-261, issn 0030-2414, 5 p.Article

Management of Recurrent Head and Neck Cancer: Recent Progress and Future DirectionsBROCKSTEIN, Bruce E.Drugs (Basel). 2011, Vol 71, Num 12, pp 1551-1559, issn 0012-6667, 9 p.Article

Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumoursKOSMAS, C; VORGIAS, G; KARABELIS, A et al.British journal of cancer. 2011, Vol 105, Num 7, pp 897-902, issn 0007-0920, 6 p.Article

Ambulatory administration of 5-day infusion ifosfamide + mesna: a pilot study in sarcoma patientsCORIAT, Romain; MIR, Olivier; CAMPS, Sandra et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 3, pp 491-495, issn 0344-5704, 5 p.Article

Effectiveness of Exogenous Albumin Administration for the Prevention of Ifosfamide-Induced EncephalopathyKETTLE, Jacob K; GRAUER, Dennis; FOLKER, Tanya L et al.Pharmacotherapy. 2010, Vol 30, Num 8, pp 812-817, issn 0277-0008, 6 p.Article

Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in ChildrenOBERLIN, Odile; FAWAZ, Oumaya; RUBIE, Hervé et al.Journal of clinical oncology. 2009, Vol 27, Num 32, pp 5350-5355, issn 0732-183X, 6 p.Article

Encephalopathy after High-Dose Ifosfamide : A Retrospective Cohort Study and Review of the LiteratureSWEISS, Karen I; BERI, Rakesh; SHORD, Stacy S et al.Drug safety. 2008, Vol 31, Num 11, pp 989-996, issn 0114-5916, 8 p.Article

Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules : an n = 1 randomized studyBRAIN, Etienne G. C; REZAI, Kevan; LOKIEC, Francois et al.British journal of clinical pharmacology. 2008, Vol 65, Num 4, pp 607-610, issn 0306-5251, 4 p.Article

Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by ChemoradiotherapyHANCOCK, Samuel Brandon; KREMPL, Greg A; CANFIELD, Vikki et al.The Laryngoscope. 2008, Vol 118, Num 8, pp 1357-1361, issn 0023-852X, 5 p.Article

Urological implications of cyclophosphamide and ifosfamideLAWSON, Malcolm; VASILARAS, Arthur; DE VRIES, Annamarie et al.Scandinavian journal of urology and nephrology. 2008, Vol 42, Num 4, pp 309-317, issn 0036-5599, 9 p.Article

Treatment of Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma with Two Ifosfamide-Based Regimens, IMVP and ICEAURER, I; MITROVIC, Z; LABAR, B et al.Journal of chemotherapy (Testo stampato). 2008, Vol 20, Num 5, pp 640-644, issn 1120-009X, 5 p.Article